Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance

Background: There is an ongoing need for targeted therapy and systemic treatment protocols for papillary thyroid carcinoma (PTC) patients. Yes activated protein-1 (YAP-1) has been found to control many targets of Hippo pathway. Annexin family is a huge family playing many roles in cellular processes...

Full description

Bibliographic Details
Main Authors: Walid Elsayed, Ola Harb, Ahmed Obaya, Dalia Elsayed, Loay Gertallah, Walid Mawla, Ahmed Abd El Fattah
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2023-01-01
Series:Middle East Journal of Cancer
Subjects:
Online Access:https://mejc.sums.ac.ir/article_48522_078a3b762f457260ecd86ae43c576777.pdf
_version_ 1797976813166657536
author Walid Elsayed
Ola Harb
Ahmed Obaya
Dalia Elsayed
Loay Gertallah
Walid Mawla
Ahmed Abd El Fattah
author_facet Walid Elsayed
Ola Harb
Ahmed Obaya
Dalia Elsayed
Loay Gertallah
Walid Mawla
Ahmed Abd El Fattah
author_sort Walid Elsayed
collection DOAJ
description Background: There is an ongoing need for targeted therapy and systemic treatment protocols for papillary thyroid carcinoma (PTC) patients. Yes activated protein-1 (YAP-1) has been found to control many targets of Hippo pathway. Annexin family is a huge family playing many roles in cellular processes. Annexin A10 (ANXA10) is a member of annexin family. Uncoordinated-5D (UNC5D), a recently discovered Unc5 family member which is found in normal tissues and downregulated in cancer cell lines and tissues. Aim of the study was to assess the expression of YAP-1, ANXA10, and UNC5D in PTC and in non-neoplastic tissues of thyroid gland using immunohistochemistry to evaluate their clinical significance and prognostic values in PTC patients.Method: In the present prospective study, we took samples from 60 patients with PTC and 30 samples from non-neoplastic thyroid tissues for YAP-1, ANXA10, and UNC5D immunohistochemistry. All the patients were followed up for assessment of the prognostic, clinical, and pathological of their expression.Results: Upregulation of YAP-1 and ANXA10 in addition to downregulation of UNC5D was found in PTC tissues more than non-neoplastic thyroid tissues. In PTC tissues, there were positive associations between high YAP-1 and ANXA10 expression, low UNC5D expression, tumor size (P = 0.022, 0.011, 0.014), presence of lymph node metastases (P = 0.005, < 0.001, 0.008), and inferior disease-free survival rate (P = 0.003, 0.01, 0.03).Conclusion: Upregulation of YAP-1 and ANXA10 expression and downregulation of UNC5D was associated with bad clincopathological criteria, disease progression, high incidence of disease recurrence, and poor survival.
first_indexed 2024-04-11T04:56:55Z
format Article
id doaj.art-cf37e822846946159c174deab26f7d6c
institution Directory Open Access Journal
issn 2008-6709
2008-6687
language English
last_indexed 2024-04-11T04:56:55Z
publishDate 2023-01-01
publisher Shiraz University of Medical Sciences
record_format Article
series Middle East Journal of Cancer
spelling doaj.art-cf37e822846946159c174deab26f7d6c2022-12-26T09:11:34ZengShiraz University of Medical SciencesMiddle East Journal of Cancer2008-67092008-66872023-01-01141294010.30476/mejc.2022.89869.155148522Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical SignificanceWalid Elsayed0Ola Harb1Ahmed Obaya2Dalia Elsayed3Loay Gertallah4Walid Mawla5Ahmed Abd El Fattah6Department of Pathology, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Pathology, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Clinical Oncology and Nuclear Medicine, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of Medical Oncology, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of General Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of General Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptDepartment of General Surgery, Faculty of Medicine, Zagazig University, Zagazig, EgyptBackground: There is an ongoing need for targeted therapy and systemic treatment protocols for papillary thyroid carcinoma (PTC) patients. Yes activated protein-1 (YAP-1) has been found to control many targets of Hippo pathway. Annexin family is a huge family playing many roles in cellular processes. Annexin A10 (ANXA10) is a member of annexin family. Uncoordinated-5D (UNC5D), a recently discovered Unc5 family member which is found in normal tissues and downregulated in cancer cell lines and tissues. Aim of the study was to assess the expression of YAP-1, ANXA10, and UNC5D in PTC and in non-neoplastic tissues of thyroid gland using immunohistochemistry to evaluate their clinical significance and prognostic values in PTC patients.Method: In the present prospective study, we took samples from 60 patients with PTC and 30 samples from non-neoplastic thyroid tissues for YAP-1, ANXA10, and UNC5D immunohistochemistry. All the patients were followed up for assessment of the prognostic, clinical, and pathological of their expression.Results: Upregulation of YAP-1 and ANXA10 in addition to downregulation of UNC5D was found in PTC tissues more than non-neoplastic thyroid tissues. In PTC tissues, there were positive associations between high YAP-1 and ANXA10 expression, low UNC5D expression, tumor size (P = 0.022, 0.011, 0.014), presence of lymph node metastases (P = 0.005, < 0.001, 0.008), and inferior disease-free survival rate (P = 0.003, 0.01, 0.03).Conclusion: Upregulation of YAP-1 and ANXA10 expression and downregulation of UNC5D was associated with bad clincopathological criteria, disease progression, high incidence of disease recurrence, and poor survival.https://mejc.sums.ac.ir/article_48522_078a3b762f457260ecd86ae43c576777.pdfyap-1 proteinanxa10unc5dptcimmunohistochemistryprognosis
spellingShingle Walid Elsayed
Ola Harb
Ahmed Obaya
Dalia Elsayed
Loay Gertallah
Walid Mawla
Ahmed Abd El Fattah
Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
Middle East Journal of Cancer
yap-1 protein
anxa10
unc5d
ptc
immunohistochemistry
prognosis
title Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
title_full Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
title_fullStr Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
title_full_unstemmed Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
title_short Expressions of YAP-1, ANXA10, and UNC5D in Tissues of Papillary Thyroid Carcinoma; Prognostic, Pathological, and Clinical Significance
title_sort expressions of yap 1 anxa10 and unc5d in tissues of papillary thyroid carcinoma prognostic pathological and clinical significance
topic yap-1 protein
anxa10
unc5d
ptc
immunohistochemistry
prognosis
url https://mejc.sums.ac.ir/article_48522_078a3b762f457260ecd86ae43c576777.pdf
work_keys_str_mv AT walidelsayed expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT olaharb expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT ahmedobaya expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT daliaelsayed expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT loaygertallah expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT walidmawla expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance
AT ahmedabdelfattah expressionsofyap1anxa10andunc5dintissuesofpapillarythyroidcarcinomaprognosticpathologicalandclinicalsignificance